Skip to content

The neural mechanism of relapse in patients with alcohol use disorder-a cross-sectional study

The neural mechanism of relapse in patients with alcohol use disorder-a cross-sectional study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049961
Enrollment
Unknown
Registered
2021-08-15
Start date
2021-08-16
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol use disorder

Interventions

group 1:Alcohol use disorder cross-sectional
group 2:Healthy Control
group 3:Alcohol use disorder longitudinal

Sponsors

Shandong Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Good health; 2. Meet the ICD-10 clinical diagnostic criteria for alcohol use disorder; 3. Agree to deep transcranial magnetic (dTMS) stimulation and treatment; 4. Age between 18-60 years old, male; 5. Junior high school education level or above; 6. Willing to participate in this study and sign the informed consent; 7. Seek to reduce or stop drug use.

Exclusion criteria

Exclusion criteria: 1. There are contraindications to transcranial magnetic (TMS) treatment, such as metal implantation in the brain, cochlear implants, increased intracranial pressure, brain trauma, cranial insufficiency, brain tumor, encephalitis, cerebrovascular disease, cerebral metabolic disease; built-in heart Pacemaker, history of heart disease; high blood pressure; history of epilepsy, family history of epilepsy, long-term use of antiepileptic drugs; sleep deprivation. 2. Suffering from other mental illnesses than substance-related and addictive disorders; 3. Serious physical disease or major organ disease; 4. Infectious diseases; 5. First-degree relatives suffering from mental illness; 6. Inability to safely initiate withdrawal for 24 hours; 7. Intellectual impairment (IQ<90).

Design outcomes

Primary

MeasureTime frame
clinical outcomes;Neuropsychological (Such as depression, anxiety, craving);EEG indicators;relapse;behavioral task;

Countries

China

Contacts

Public ContactWei Yuan

Shandong Mental Health Center

ytf0707@126.com+86 18705317378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026